03614nam 2200589 a 450 99621816710331620230617025016.01-280-28482-X97866102848250-470-70943-X0-470-98683-20-470-98684-01-4051-2336-2(CKB)111087027742280(EBL)214167(OCoLC)475920133(SSID)ssj0000104344(PQKBManifestationID)11122179(PQKBTitleCode)TC0000104344(PQKBWorkID)10084900(PQKB)11782560(MiAaPQ)EBC214167(EXLCZ)9911108702774228020020620d2003 uy 0engur|n|---|||||txtccrAnxiety disorders[electronic resource] /edited by D.J. Nutt, J.C. BallengerMalden, Mass. Blackwell Science20031 online resource (556 p.)Description based upon print version of record.0-632-05938-9 Includes bibliographical references and index.Anxiety Disorders; Contents; Contributors; Preface; PART ONE: Introduction; 1. Conceptual Antecedents of the Anxiety Disorders; PART TWO: Symptoms and Syndromes; 2. Relationships Among Anxiety Disorders: Patterns and Implications; 3. Panic Disorder: Symptoms and Syndromes; 4. Generalized Anxiety Disorder; 5. Post-traumatic Stress Disorder; 6. Obsessive-compulsive Disorder; 7. Social Anxiety Disorder; 8. Sleep Aspects of Anxiety Disorders; 9. Childhood Antecedents of Adult Anxiety Disorders; 10. Anxiety and Schizophrenia; PART THREE: Mechanisms; 11. Neurochemical Aspects of Anxiety12. Brain Imaging and Anxiety Disorders13. Genetic Dissection of Anxiety and Related Disorders; 14. Respiration and Anxiety; 15. Pharmacological Challenge Agents In Anxiety; 16. Panic Disorder and Medical Illness; PART FOUR: Treatments; 17. Benzodiazepines; 18. Selective Serotonin Reuptake Inhibitors in the Treatment of the Anxiety Disorders; 19. Treatment of Anxiety Disorders with Tricyclic Antidepressants; 20. Buspirone in the Treatment of Anxiety Disorders; 21. Antihistamines in the Treatment of Psychic and Somatic Anxiety States; 22. Anxiety Disorders: New Antidepressants23. Cognitive Behavioral Treatment of Anxiety Disorders24. Exposure Therapy in the Treatment of Anxiety Disorders; 25. Anxiety Disorders: Alternative Drug Treatments; 26. Physical Treatments; 27. Herbal Therapy and Anxiety; PART FIVE: CONCLUSION; 28. Anxiety Disorders: Current Needs and Future Prospects; IndexRapid developments in recent years in basic science and pharmacology has greatly increased understanding of the causes of anxiety disorders. This has led to a large number of new drug treatments from the pharmaceutical industry. This book makes sense of these advances and presents a coherent account of diagnosis and management from the clinical point of view. Chapters are in the form of surveys and digests of the recent literature and are interspersed with clinical guidelines, diagnostic and therapeutic points and are well illustrated.AnxietyAnxiety.616.85/223061616.85223Nutt David J.1951-971935Ballenger James C983443MiAaPQMiAaPQMiAaPQBOOK996218167103316Anxiety disorders2245010UNISA